BioCentury
ARTICLE | Company News

Bend Research Inc., Pfizer deal

October 27, 2008 7:00 AM UTC

The companies converted Pfizer's rights to Bend's drug delivery technology to non-exclusive from exclusive, except for undisclosed technologies to which the pharma retains exclusive, worldwide rights....